* Ruane, Cunniff & Goldfarb Inc. reports 4.72% passive
stake in Valeant Pharmaceuticals International Inc as
of May 31, 2016 – SEC filing
The post BRIEF-Ruane, Cunniff & Goldfarb cuts passive stake in Valeant Pharmaceuticals to 4.72 pct appeared first on NASDAQ.